Forbes - What To Know About Pfizer’s Vaccine

Plus: UK reports highest Covid-19 death toll in 6 months

People are still talking about Pfizer’s Covid-19 vaccine success from yesterday-- though some are more skeptical than others. As President Trump continues to falsely take credit for the company’s success, Spain has already ordered 20 million doses of the vaccine to arrive in early 2021. Not to fear, however: HHS Secretary Alex Azar said today that he thinks that there will be enough doses of a Covid-19 vaccine for all Americans by next spring. There are still some significant hurdles to the release of the vaccine, however. As senior healthcare contributor Judy Stone points out, no peer-reviewed data from the Pfizer trials has been released yet. The FDA still has to review and authorize the vaccine as well. And not all Covid-19 vaccines are finding success -- Brazil recently suspended a trial of a Covid-19 vaccine developed in China after reporting an unspecified “serious adverse event.”

Business

Senate Republicans released a $1.4 trillion spending plan today, but it doesn’t include any coronavirus aid. 

Eli Lilly’s antibody treatment was granted an emergency use authorization from the FDA to treat Covid-19. 

Science & Health

Some college students are traveling home for Thanksgiving-- will they bring Covid-19 home for the holiday?

These videos show why using N95 masks with valves won’t prevent the spread of Covid-19. 

A new study finds that one in five Covid-19 patients are diagnosed with a mental illness within three months of testing positive, highlighting the mental toll of being sick with the virus. 

Some endangered marine mammals are at risk of getting Covid-19 -- here’s why. 

On The Upside

Magic Mushroom Meds: Just as voters in Oregon and DC decided to decriminalize the use of psilocybin, the active ingredient in "magic mushrooms," more research confirms that treatment with psilocybin, along with psychotherapy, can help treat anxiety and depression.